POZ Community Forums
Meds, Mind, Body & Benefits => Research News & Studies => Topic started by: phildinftlaudy on September 13, 2011, 12:04:01 pm
-
For those in the New York City area that may be interested in attending, the panel of presenters look very interesting and knowledgeble: (http://www.treatmentactiongroup.org/base.aspx?id=4656)
Pre-Exposure Prophylaxis (PrEP) to Prevent HIV: What's NEXT?
A community forum to discuss WHAT WE KNOW about PrEP and WHAT is “NEXT” in the used of HIV medications as a prevention tool to reduce the risk of HIV Infection.
Tuesday, October 18, 2011
6:00 pm – 7:30 pm
LGBT Center
208 West 13th Street
New York, NY 10011
Presentation by Roy Gulick, MD, MPH, Professor of Medicine, Chief of the Division of Infectious Diseases, Weill Cornell Medical College
Guests Panelists:
Kali Lindsey, Director of Government Affairs and Communications, National Minority AIDSCouncil
Lyn C. Stevens, Deputy Director, New York State Department of Health, AIDS Institute
Todd Stroberg, RN, Research Study Coordinator, Cornell Clinical Trials Unit
Mitchell Warren, Executive Director, AVAC: Global Advocacy for HIV Prevention
Moderator:
Moises Agosto, Director of Treatment Education, Adherence & Mobilization, National Minority AIDS Council
Sponsors: Weill Cornell Medical College NYS DOH AIDS Institute, and the National Minority AIDS Council (NMAC)
Co-sponsors: Center for HIV/AIDS Educational Studies and Training (CHEST), Gay Men’s Health Crisis (GMHC), Global Advocacy for HIV Prevention (AVAC), Latino Commission on AIDS (LCOA), and Treatment Action Group (TAG).
This Community Forum is free and open to the general public.
For more information, contact Luis (212) 746-7206 or email: lul2008@med.cornell.edu